SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-026188
Filing Date
2019-12-16
Accepted
2019-12-16 06:02:27
Documents
5
Period of Report
2019-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121219_adialpharma.htm 8-K 36165
2 AMENDMENT TO STATEMENT OF WORK UNDER MASTER SERVICES AGREEMENT DATED DECEMBER 12 f8k121219ex10-1_adialpharma.htm EX-10.1 24662
3 GUARANTY, DATED DECEMBER 12, 2019, EXECUTED BY DR. BANKOLE JOHNSON f8k121219ex10-2_adialpharma.htm EX-10.2 43761
4 PLEDGE AND SECURITY AGREEMENT, DATED DECEMBER 12, 2019 f8k121219ex10-3_adialpharma.htm EX-10.3 41772
5 LOCK-UP AGREEMENT, DATED DECEMBER 12, 2019 f8k121219ex10-4_adialpharma.htm EX-10.4 28103
  Complete submission text file 0001213900-19-026188.txt   175825
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 191285764
SIC: 2834 Pharmaceutical Preparations